Skip to main content
Intermediate Technical In the Industry Vocabulary Test

cytarabine

Pronunciation: sy-TARE-ah-been

An antimetabolite chemotherapy drug used extensively in pediatric acute leukemia treatment protocols.

Full Definition

Cytarabine (ara-C) is a pyrimidine nucleoside analog that functions as an antimetabolite chemotherapy agent. It is a cornerstone drug in the treatment of pediatric acute lymphoblastic leukemia and acute myeloid leukemia. Cytarabine works by inhibiting DNA synthesis and is typically administered intravenously or intrathecally. Common side effects include myelosuppression, gastrointestinal toxicity, and at high doses, cerebellar toxicity.

Usage

Usage note: Monitor for cerebellar toxicity with high-dose regimens.

In Context

  • "High-dose cytarabine was administered during the consolidation phase of AML treatment." — Treatment protocol
  • "The patient developed cerebellar toxicity following cytarabine infusion." — Adverse event report

Also known as

ara-C cytosine arabinoside

Don't confuse with

cytoxan carboplatin

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON